Press Releases

2017

Relevium Announces Private Placement and Provides Update on BioGanix Aquisition

Relevium Technologies Inc., a consolidator of e-commerce assets in Health and Wellness, is pleased to provide the following update to its press release of December 22, 2016 announcing a binding letter of intent (the “LOI”) to acquire the assets of BioGanix Limited (“BGL”), a privately-held nutraceutical company in Houston, Texas focused on heart, brain, digestive health and joint support products sold through primarily through e-commerce platforms.

Relevium Provides Update on BioGanix and Trading Halt

Relevium Technologies Inc. a consolidator of e-commerce assets in Health and Wellness, announced on December 22, 2016 that it had executed a binding letter of intent (the “LOI”) to acquire the assets of BioGanix Limited (“BGL”), a privately- held nutraceutical company based in Houston, Texas and focused on heart, brain, digestive health and joint support products sold through primarily through e-commerce platforms.

2016

Relevium Appoints Advisory Board

Relevium Technologies Inc. is pleased to announce the appointment of Martin M. Scullion and Quinn Roukema to the Advisory Board of the Corporation.

Relevium Completes Maestro Private Placement

Relevium Technologies Inc. is pleased to announce it has completed the previously announced private placement by Maestro Capital Corporation (the “Private Placement”).

Relevium Announces Private Placement by Maestro Capital

Relevium Technologies Inc. in conjunction with Maestro Capital Inc. is pleased to announce that the two parties have agreed to the terms of participation by Maestro in a non-brokered private placement offering.

Relevium Technologies Returns 8,612,500 Shares to Treasury

Relevium Technologies Inc. is pleased to announce it has received approval from the TSX Venture Exchange regarding the cancellation of 8,612,500 previously issued shares relating to the acquisition of the assets of BIOflex Medical Magnetics, Inc., leaving the Company with a total of 29,525,966 common shares outstanding.

Relevium Technologies Provides Corporate Update

Relevium Technologies Inc. is pleased to provide an update regarding the previously announced corporate roll-up strategy, focused on acquiring products, technologies or companies within the rapidly expanding global health and wellness sector.

Relevium Technologies Enters into Exclusive Supply Agreement

Relevium Technologies Inc. is pleased to provide an update on its corporate strategy, which is primarily focused on the acquisition of products or companies within three major verticals in the health and wellness sector: Pain Relief, Recovery and Performance.

Relevium Technologies Announces Strategic Additions to Advisory Board

Relevium Technologies Inc. is pleased to announce the formation of its new corporate advisory board comprised of individuals with a wealth of experience in sports therapy, functional movement and consumer goods marketing in order to assist with the selection, negotiation and integration of potential business acquisitions.

2015